Portfolio company
Adaptilens
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
Adaptilens develops flexible intraocular lenses that mimic the natural focus of the eye for patients undergoing cataract surgery to eliminate dependence on glasses.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
VisusNano
This company develops drug-eluting intraocular lens implants for patients undergoing cataract surgery to eliminate the need for post-operative eye drops.
ForSight VISION6 Inc
The company develops accommodating intraocular lenses for ophthalmic surgeons to restore precise vision across all distances for patients following cataract surgery.
Glakolens
This company develops sensor-embedded contact lenses that provide continuous intraocular pressure monitoring for patients with glaucoma and ocular hypertension.
Azalea Vision
This company develops smart contact lenses with integrated microelectronics to treat patients suffering from vision disorders and light sensitivity.
EyeYon
This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.
2eyesVision
This company develops visual simulators that allow patients to experience multifocal corrections before undergoing cataract surgery or receiving contact lens fittings.
IXI
This company develops autofocus glasses using real-time eye-tracking and dynamic lens technology for consumers with vision correction needs.
SpyGlass Pharma, Inc
The company develops an intraocular lens drug delivery system for patients with glaucoma to provide long-term medication during cataract surgery.
